Registrieren

Registierung erfolgt in Kürze...
Fleebs-Logo
Details werden geladen...

Pharma mutual funds: Kotak Healthcare leads 1-year returns at over 28% — here’s how others performed | Mint

Pharma and healthcare mutual funds have delivered positive returns over the last 1 year, but performance has varied sharply across schemes. While some active funds have gained more than 25%, several others have posted much lower returns.

Ähnliche Seiten

https://www.livemint.com/money/personal-finance/10-pharma-mutual-funds-delivered-over-20-in-one-year-hdfc-pharma-leads-with-28-66-return-11788336512520.html

10 pharma mutual funds delivered over 20% in one year: HDFC Pharma leads with 28.66% return | Mint

https://www.livemint.com/money/personal-finance/10-pharma-mutual-funds-delivered-over-20-in-one-year-hdfc-pharma-leads-with-28-66-return-11788336512520.html
https://www.livemint.com/money/personal-finance/best-mid-cap-mutual-funds-12-funds-delivered-over-18-10-year-sip-returns-11785223583962.html

Best mid-cap mutual funds: 12 funds delivered over 18% 10-year SIP returns | Mint

https://www.livemint.com/money/personal-finance/best-mid-cap-mutual-funds-12-funds-delivered-over-18-10-year-sip-returns-11785223583962.html
https://www.livemint.com/money/personal-finance/equity-funds-performance-quant-small-cap-tops-10-year-sip-returns-at-over-25-sundaram-value-trails-11787852143950.html

Equity funds performance: Quant Small Cap tops 10-year SIP returns at over 25%; Sundaram Value trails | Mint

https://www.livemint.com/money/personal-finance/equity-funds-performance-quant-small-cap-tops-10-year-sip-returns-at-over-25-sundaram-value-trails-11787852143950.html
https://www.livemint.com/money/personal-finance/highest-3-year-sip-returns-sbi-gold-fund-leads-at-44-11-while-small-cap-mid-cap-and-pharma-funds-follow-11787646652436.html

Highest 3-year SIP returns: SBI Gold Fund leads at 44.11%, while small-cap, mid-cap and pharma funds follow | Mint

https://www.livemint.com/money/personal-finance/highest-3-year-sip-returns-sbi-gold-fund-leads-at-44-11-while-small-cap-mid-cap-and-pharma-funds-follow-11787646652436.html
https://economictimes.indiatimes.com/mf/analysis/pharma-amp-healthcare-funds-lead-5-year-returns-while-flexicap-and-largecap-deliver-stable-performance/slideshow/132709573.cms

Pharma & healthcare funds lead 5-year returns, while flexicap and largecap deliver stable performance - Looking for better SIP returns? | The Economic Times

https://economictimes.indiatimes.com/mf/analysis/pharma-amp-healthcare-funds-lead-5-year-returns-while-flexicap-and-largecap-deliver-stable-performance/slideshow/132709573.cms
https://www.livemint.com/money/personal-finance/10000-sip-to-30-lakh-these-large-midcap-mutual-funds-led-10-year-returns-11784200202660.html

₹10,000 SIP to ₹30 lakh: These large & midcap mutual funds led 10-year returns | Mint

https://www.livemint.com/money/personal-finance/10000-sip-to-30-lakh-these-large-midcap-mutual-funds-led-10-year-returns-11784200202660.html